Cutera, Inc. (CUTR) Shares Bought by Schwab Charles Investment Management Inc.

Schwab Charles Investment Management Inc. increased its holdings in shares of Cutera, Inc. (NASDAQ:CUTR) by 14.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 37,434 shares of the medical device company’s stock after buying an additional 4,786 shares during the quarter. Schwab Charles Investment Management Inc. owned 0.27% of Cutera worth $1,698,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also modified their holdings of the company. State Street Corp grew its holdings in shares of Cutera by 12.6% during the second quarter. State Street Corp now owns 203,059 shares of the medical device company’s stock valued at $5,258,000 after buying an additional 22,700 shares in the last quarter. Russell Investments Group Ltd. grew its holdings in shares of Cutera by 55.2% during the third quarter. Russell Investments Group Ltd. now owns 171,515 shares of the medical device company’s stock valued at $7,093,000 after buying an additional 60,986 shares in the last quarter. Ameriprise Financial Inc. grew its holdings in shares of Cutera by 4.1% during the third quarter. Ameriprise Financial Inc. now owns 127,600 shares of the medical device company’s stock valued at $5,276,000 after buying an additional 5,043 shares in the last quarter. OxFORD Asset Management LLP grew its holdings in shares of Cutera by 38.7% during the third quarter. OxFORD Asset Management LLP now owns 88,869 shares of the medical device company’s stock valued at $3,673,000 after buying an additional 24,779 shares in the last quarter. Finally, Cornerstone Capital Management Holdings LLC. grew its holdings in shares of Cutera by 76.0% during the third quarter. Cornerstone Capital Management Holdings LLC. now owns 85,700 shares of the medical device company’s stock valued at $3,542,000 after buying an additional 37,000 shares in the last quarter. Institutional investors and hedge funds own 95.29% of the company’s stock.

How to Become a New Pot Stock Millionaire

In other Cutera news, insider James A. Reinstein sold 7,175 shares of the business’s stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $45.35, for a total value of $325,386.25. Following the completion of the sale, the insider now owns 132,284 shares of the company’s stock, valued at $5,999,079.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Larry Laber sold 5,843 shares of the business’s stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $45.35, for a total value of $264,980.05. Following the completion of the sale, the executive vice president now directly owns 79,463 shares of the company’s stock, valued at approximately $3,603,647.05. The disclosure for this sale can be found here. 11.60% of the stock is currently owned by company insiders.

A number of analysts recently issued reports on CUTR shares. Zacks Investment Research cut Cutera from a “hold” rating to a “sell” rating in a research report on Tuesday, December 26th. BidaskClub raised Cutera from a “hold” rating to a “buy” rating in a research report on Tuesday, December 12th. Gabelli reissued a “buy” rating on shares of Cutera in a research report on Friday, February 16th. Finally, Stephens started coverage on Cutera in a research report on Tuesday, March 13th. They set an “overweight” rating and a $60.00 price objective for the company. One analyst has rated the stock with a hold rating, four have assigned a buy rating and two have assigned a strong buy rating to the stock. Cutera has an average rating of “Buy” and an average target price of $45.00.

Shares of Cutera stock opened at $51.95 on Friday. The stock has a market capitalization of $719.77, a price-to-earnings ratio of 68.36, a P/E/G ratio of 1.12 and a beta of 0.51. Cutera, Inc. has a 12-month low of $18.50 and a 12-month high of $55.00.

Cutera (NASDAQ:CUTR) last released its quarterly earnings data on Wednesday, February 14th. The medical device company reported $0.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.33 by $0.09. The firm had revenue of $47.60 million during the quarter, compared to analysts’ expectations of $43.96 million. Cutera had a return on equity of 18.31% and a net margin of 19.80%. The business’s revenue for the quarter was up 25.6% on a year-over-year basis. During the same quarter last year, the firm earned $0.30 earnings per share. equities research analysts anticipate that Cutera, Inc. will post 1.1 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Cutera, Inc. (CUTR) Shares Bought by Schwab Charles Investment Management Inc.” was published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this news story on another site, it was copied illegally and republished in violation of United States & international copyright law. The original version of this news story can be viewed at https://www.tickerreport.com/banking-finance/3298861/cutera-inc-cutr-shares-bought-by-schwab-charles-investment-management-inc.html.

About Cutera

Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.

Institutional Ownership by Quarter for Cutera (NASDAQ:CUTR)

Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Valvoline  & Quaker Chemical  Critical Analysis
Valvoline & Quaker Chemical Critical Analysis
Catcoin 24 Hour Trading Volume Hits $286.00
Catcoin 24 Hour Trading Volume Hits $286.00
Analysts Expect Barrick Gold  Will Announce Quarterly Sales of $1.78 Billion
Analysts Expect Barrick Gold Will Announce Quarterly Sales of $1.78 Billion
ETHLend  Hits Market Cap of $82.36 Million
ETHLend Hits Market Cap of $82.36 Million
Solarflarecoin  Price Tops $0.0059 on Major Exchanges
Solarflarecoin Price Tops $0.0059 on Major Exchanges
Fortis  & PNM Resources  Head to Head Review
Fortis & PNM Resources Head to Head Review


© 2006-2018 Ticker Report. Google+.